Literature DB >> 31907561

Hypoxia: a barricade to conquer the pancreatic cancer.

Zhen Tan1,2,3,4, Jin Xu1,2,3,4, Bo Zhang1,2,3,4, Si Shi1,2,3,4, Xianjun Yu5,6,7,8, Chen Liang9,10,11,12.   

Abstract

Pancreatic cancer (PC) remains one of the most extremely lethal malignancies worldwide due to late diagnosis and early metastasis, with a 1-year overall survival rate of approximately 20%. The hypoxic microenvironment, induced by intratumoral hypoxia, promotes tumor invasion and progression, leading to chemotherapy or radiotherapy resistance and eventual mortality after treatment of PC. However, the role of the hypoxic microenvironment in PC is complicated and requires further investigation. In this article, we review recent advances regarding the regulation of malignant behaviors in PC, which provide insight into the potential of hypoxic microenvironment activation therapy for the therapeutic agents.

Entities:  

Keywords:  Chemoresistant; Hypoxia-inducible factors; Tumor malignant behavior

Mesh:

Substances:

Year:  2020        PMID: 31907561     DOI: 10.1007/s00018-019-03444-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  14 in total

1.  Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling.

Authors:  Zhengle Zhang; Erhu Fang; Yuping Rong; Han Han; Qiong Gong; Yingyan Xiao; Hehe Li; Pei Mei; Hanjun Li; Zhongchao Zhu; Zhigang Tang; Jing Tao
Journal:  Am J Cancer Res       Date:  2021-01-01       Impact factor: 6.166

2.  Immunofluorescence-Based Method to Assess Cancer Biomarker in the Hypoxic Region of the Tumor.

Authors:  Leslimar Rios-Colon; Susy Kim; Yixin Su; Deepak Kumar; Gagan Deep
Journal:  Methods Mol Biol       Date:  2022

3.  Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1.

Authors:  Qian Yu; Zhong Zhang; Haijun Zhang
Journal:  Cancer Manag Res       Date:  2021-02-11       Impact factor: 3.989

4.  Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.

Authors:  Wenpeng Cao; Zhirui Zeng; Zhiwei He; Shan Lei
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

5.  Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia.

Authors:  Yan Chen; Lei Fang; Weixin Zhou; Jinghan Chang; Xiaojuan Zhang; Chuanchuan He; Chen Chen; Ruicong Yan; Yakai Yan; Yao Lu; Chuanrui Xu; Guangya Xiang
Journal:  J Nanobiotechnology       Date:  2021-08-16       Impact factor: 10.435

Review 6.  Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.

Authors:  Tiago M A Carvalho; Daria Di Molfetta; Maria Raffaella Greco; Tomas Koltai; Khalid O Alfarouk; Stephan J Reshkin; Rosa A Cardone
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

Review 7.  Pancreatic Cancer and Its Microenvironment-Recent Advances and Current Controversies.

Authors:  Kinga B Stopa; Agnieszka A Kusiak; Mateusz D Szopa; Pawel E Ferdek; Monika A Jakubowska
Journal:  Int J Mol Sci       Date:  2020-05-01       Impact factor: 5.923

Review 8.  Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer.

Authors:  Claudia Geismann; Alexander Arlt
Journal:  Cells       Date:  2020-10-25       Impact factor: 6.600

9.  A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.

Authors:  Qiwen Ben; Wei An; Yunwei Sun; Aihua Qian; Jun Liu; Duowu Zou; Yaozong Yuan
Journal:  J Exp Clin Cancer Res       Date:  2020-09-07

Review 10.  Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians.

Authors:  Dimitrios Giannis; Dimitrios Moris; Andrew S Barbas
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.